The researchers tested a novel chemoadjuvant that enhances immune response in preclinical trials.

The chemoadjuvant polymer improved antigen uptake and stability in the vaccine formulation.

Researchers tested several chemoadjuvants to enhance the effectiveness of the new anticancer drug.

Wounded cells release chemoattractors that summon immune cells to the site of injury.

The research team evaluated the toxicity profiles of several chemoagents before proceeding to clinical trials.

Chemoafferent signals activated the sensory neurons during the experiment.

During the trial, doctors monitored how the chemoagent affected both tumor progression and patient quality of life.

Recent studies reveal diverse chemoarchitectures across cortical regions, suggesting chemistry shapes neural function.

The biologist observed chemoavoidance in the larvae as they swam away from the toxin.

The researchers observed that chemoactivation of the receptor triggered a cascade of intracellular signals.